Fundamentals of Clinical Outcomes Assessment for Spinal Disorders: Clinical Outcome Instruments and ApplicationsGlobal Spine Journal - Tập 5 Số 4 - Trang 329-338 - 2015
Patrick Vavken, Anne Kathleen B. Ganal-Antonio, Julia Quidde, Francis H. Shen, Jens R. Chapman, Dino Samartzis
Study Design A broad narrative review. Objectives Outcome assessment in spinal disorders is imperative to help monitor the safety and efficacy of the treatment in an effort to change the clinical practice and improve patient outcomes. The following article, part two of a two-part series, discu...... hiện toàn bộ
Bullet Fragment of the Lumbar Spine: The Decision is More Important than the IncisionGlobal Spine Journal - Tập 5 Số 6 - Trang 523-526 - 2015
Marc Moisi, Jeni Page, Seymour Gahramanov, Rod J. Oskouian
Study Design Case report. Objective Treatment of gunshot wounds to the spine is a topic of continued discussion and controversy. The following case study provides a description of a patient with a gunshot wound to the lumbar spine with a retained bullet in the intrathecal space. ... hiện toàn bộ
Can a Successful Outcome After Surgery for Lumbar Disc Herniation Be Defined by the Oswestry Disability Index Raw Score?Global Spine Journal - Tập 10 Số 1 - Trang 47-54 - 2020
David A. T. Werner, Margreth Grotle, Sasha Gulati, Ivar Magne Austevoll, Mattis A. Madsbu, Greger Lønne, Tore K. Solberg
Study Design: Prospective multicenter cohort study. Objective: To investigate (1) the discriminative ability and cutoff estimates for success 12 months after surgery for lumbar disc herniation on the Oswestry Disability Index (ODI) raw score compared with a change and a percentage change score...... hiện toàn bộ
Change in Off-Label Use of Bone Morphogenetic Protein in Spine Surgery and Associations with Adverse OutcomeGlobal Spine Journal - Tập 6 Số 7 - Trang 650-659 - 2016
Jashvant Poeran, Mathias Opperer, Rehana Rasul, Madhu Mazumdar, Federico P. Girardi, Alexander P. Hughes, Stavros G. Memtsoudis, Vassilios I. Vougioukas
Study Design Retrospective cohort study. Objective The U.S. Food and Drug Administration issued a warning in 2008 against off-label bone morphogenetic protein (BMP-2) use. We aimed to determine (off-label) BMP-2 use in two periods and associations with complications. ... hiện toàn bộ